Operating Income (Loss) in USD of Ocean Biomedical, Inc. from Q2 2021 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ocean Biomedical, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q2 2021 to Q1 2025.
  • Ocean Biomedical, Inc. Operating Income (Loss) for the quarter ending 31 Mar 2025 was -$958,000.000, a 61% decline year-over-year.
  • Ocean Biomedical, Inc. Operating Income (Loss) for the twelve months ending 31 Mar 2025 was -$4,161,000.000, a 23.3% increase year-over-year.
  • Ocean Biomedical, Inc. annual Operating Income (Loss) for 2024 was -$3,798,000.000, a 62.8% increase from 2023.
  • Ocean Biomedical, Inc. annual Operating Income (Loss) for 2023 was -$10,214,000.000, a 36.6% increase from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Ocean Biomedical, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$4,161,000 -$958,000 -$363,000 -61% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 -$3,798,000 -$1,753,000 -$2,413,000 -3.7% 01 Oct 2024 31 Dec 2024 10-K 08 Apr 2025
Q3 2024 -$1,385,000 -$768,000 +$1,887,000 +71.1% 01 Jul 2024 30 Sep 2024 10-Q 13 Jan 2025
Q2 2024 -$3,272,000 -$682,000 +$2,150,000 +75.9% 01 Apr 2024 30 Jun 2024 10-Q 23 Dec 2024
Q1 2024 -$5,422,000 -$595,000 +$4,792,000 +89% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 -$10,214,000 $660,000 +$1,598,000 01 Oct 2023 31 Dec 2023 10-K 08 Apr 2025
Q3 2023 -$11,812,000 -$2,655,000 +$518,000 +16.3% 01 Jul 2023 30 Sep 2023 10-Q 13 Jan 2025
Q2 2023 -$12,330,000 -$2,832,000 +$4,068,000 +59% 01 Apr 2023 30 Jun 2023 10-Q 23 Dec 2024
Q1 2023 -$16,398,000 -$5,387,000 -$277,000 -5.4% 01 Jan 2023 31 Mar 2023 10-Q 23 Dec 2024
Q4 2022 -$16,121,000 -$938,000 01 Oct 2022 31 Dec 2022 10-K 25 Nov 2024
Q3 2022 -$3,173,000 -$3,130,282 -73.3% 01 Jul 2022 30 Sep 2022 10-Q 15 Apr 2024
Q2 2022 -$6,900,000 -$6,899,918 01 Apr 2022 30 Jun 2022 10-Q/A 15 Apr 2024
Q1 2022 -$5,110,000 01 Jan 2022 31 Mar 2022 10-Q/A 15 Apr 2024
Q3 2021 -$42,718 01 Jul 2021 30 Sep 2021 10-Q 17 Oct 2022
Q2 2021 -$82* 17 Jun 2021 30 Jun 2021 10-Q 11 Jul 2022

Ocean Biomedical, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$3,798,000 +$6,416,000 +62.8% 01 Jan 2024 31 Dec 2024 10-K 08 Apr 2025
2023 -$10,214,000 +$5,907,000 +36.6% 01 Jan 2023 31 Dec 2023 10-K 08 Apr 2025
2022 -$16,121,000 01 Jan 2022 31 Dec 2022 10-K 25 Nov 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.